» Articles » PMID: 19923923

Epigenetic Control of the Expression of a Primate-specific MicroRNA Cluster in Human Cancer Cells

Overview
Journal Epigenetics
Specialty Genetics
Date 2009 Nov 20
PMID 19923923
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Many of the known microRNAs (miRNAs) are encoded by polycistronic transcripts and are thought to be co-expressed. In this study, we discovered that the expression of a large miRNA cluster (C19MC) on human chromosome 19 is upregulated by the demethylating agent, 5-aza-2'-deoxycytidine (5-Aza-dC), in AGS gastric cancer cells. We found that C19MC was rarely expressed in most cells, but its expression was restored through DNA demethylation. We confirmed that this miRNA cluster was mainly expressed in the placenta, as previously reported. Furthermore, its expression pattern was highly correlated with the methylation state of a distal CpG-rich region located about 17.6 kb upstream of the miRNA cluster. Using combined bisulfite restriction analysis (COBRA) and bisulfite-sequencing techniques, we determined that this CpG-rich region is hypermethylated in the AGS and HeLa cells, but hypomethylated in the placenta tissue. In conclusion, we demonstrated that the expression pattern of the C19MC was activated in human cancer cells through demethylation of a CpG-rich region.

Citing Articles

Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption.

Bailey S, Ferraresso M, Alonso-Crisostomo L, Ward D, Smith S, Nicholson J Br J Cancer. 2023; 129(9):1451-1461.

PMID: 37789102 PMC: 10628203. DOI: 10.1038/s41416-023-02453-1.


Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer.

Ware A, Satyamoorthy K, Paul B Funct Integr Genomics. 2023; 23(3):266.

PMID: 37542643 PMC: 10404189. DOI: 10.1007/s10142-023-01191-0.


Crosstalk between miRNAs and DNA Methylation in Cancer.

Saviana M, Le P, Micalo L, Del Valle-Morales D, Romano G, Acunzo M Genes (Basel). 2023; 14(5).

PMID: 37239435 PMC: 10217889. DOI: 10.3390/genes14051075.


MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer.

Ghamlouche F, Yehya A, Zeid Y, Fakhereddine H, Fawaz J, Liu Y Transl Oncol. 2023; 28:101613.

PMID: 36608541 PMC: 9827391. DOI: 10.1016/j.tranon.2022.101613.


Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells.

Chhabra R, Rockfield S, Guergues J, Nadeau O, Hill R, Stevens Jr S Sci Rep. 2021; 11(1):6270.

PMID: 33737539 PMC: 7973504. DOI: 10.1038/s41598-021-85342-y.